Diagnostic challenges and standard therapy

被引:10
作者
Kyle, RA [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Med & Lab Med, Div Hematol & Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1053/shem.2001.21070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:11 / 14
页数:4
相关论文
共 14 条
[1]   RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE [J].
CAZZOLA, M ;
MESSINGER, D ;
BATTISTEL, V ;
BRON, D ;
CIMINO, R ;
ENLLERZIEGLER, L ;
ESSERS, U ;
GREIL, R ;
GROSSI, A ;
JAGER, G ;
LEMEVEL, A ;
NAJMAN, A ;
SILINGARDI, V ;
SPRIANO, M ;
VANHOOF, A ;
EHMER, B .
BLOOD, 1995, 86 (12) :4446-4453
[2]   A randomized trial of maintenance interferon following a high-dose chemotherapy in multiple myeloma: long-term follow-up results [J].
Cunningham, D ;
Powles, R ;
Malpas, J ;
Raje, N ;
Milan, S ;
Viner, C ;
Montes, A ;
Hickish, T ;
Nicolson, M ;
Johnson, P ;
Treleaven, J ;
Raymond, J ;
Gore, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (02) :495-502
[3]   COMBINATION CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE IN THE TREATMENT OF MULTIPLE-MYELOMA - AN OVERVIEW OF PUBLISHED TRIALS [J].
GREGORY, WM ;
RICHARDS, MA ;
MALPAS, JS .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :334-342
[4]   IMMUNOFLUORESCENCE LABELING INDEXES IN MYELOMA AND RELATED MONOCLONAL GAMMOPATHIES [J].
GREIPP, PR ;
WITZIG, TE ;
GONCHOROFF, NJ ;
HABERMANN, TM ;
KATZMANN, JA ;
OFALLON, WM ;
KYLE, RA .
MAYO CLINIC PROCEEDINGS, 1987, 62 (11) :969-977
[5]   BENIGN MONOCLONAL GAMMOPATHY - AFTER 20 TO 35 YEARS OF FOLLOW-UP [J].
KYLE, RA .
MAYO CLINIC PROCEEDINGS, 1993, 68 (01) :26-36
[6]   SMOLDERING MULTIPLE-MYELOMA [J].
KYLE, RA ;
GREIPP, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (24) :1347-1349
[7]   ERYTHROPOIETIN TREATMENT OF ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA [J].
LUDWIG, H ;
FRITZ, E ;
KOTZMANN, H ;
HOCKER, P ;
GISSLINGER, H ;
BARNAS, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (24) :1693-1699
[8]   MAINTENANCE TREATMENT WITH RECOMBINANT INTERFERON ALFA-2B IN PATIENTS WITH MULTIPLE-MYELOMA RESPONDING TO CONVENTIONAL INDUCTION CHEMOTHERAPY [J].
MANDELLI, F ;
AVVISATI, G ;
AMADORI, S ;
BOCCADORO, M ;
GERNONE, A ;
LAUTA, VM ;
MARMONT, F ;
PETRUCCI, MT ;
TRIBALTO, M ;
VEGNA, ML ;
DAMMACCO, F ;
PILERI, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) :1430-1434
[9]   MANAGEMENT OF MYELOMA KIDNEY - AN ANTI-LIGHT-CHAIN APPROACH [J].
MISIANI, R ;
TIRABOSCHI, G ;
MINGARDI, G ;
MECCA, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (01) :28-33
[10]   Prophylactic antibiotics for the prevention of early infection in multiple myeloma [J].
Oken, MM ;
Pomeroy, C ;
Weisdorf, D ;
Bennett, JM .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06) :624-628